Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications
Piero Ruscitti, Ilenia Di Cola, Claudia Di Muzio, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 7, pp. 103114-103114
Closed Access | Times Cited: 18

Showing 18 citing articles:

Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 24
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 7-8, pp. 103581-103581
Closed Access | Times Cited: 5
Monocyte–macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis‐related interstitial lung disease
Jia Shi, Xiaoya Pei, Jinmin Peng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes
Chih‐Cheng Lai, Chi‐Kuei Hsu, Shun‐Chung Hsueh, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Closed Access | Times Cited: 16
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e003419-e003419
Open Access | Times Cited: 8
The latest advances in the use of biological DMARDs to treat Still’s disease
Ilenia Di Cola, Piero Ruscitti
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 63-75
Closed Access | Times Cited: 2
AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis
Ruru Guo, Xuesong Liu, Yixuan Li, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 4, pp. 1636-1644
Closed Access | Times Cited: 11
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli, et al.
Seminars in Immunology (2021) Vol. 58, pp. 101632-101632
Closed Access | Times Cited: 14
Clinical features of macrophage activation syndrome in adult dermatomyositis: A single‐center retrospective case‐control study
Dingxian Zhu, Shuni Ying, Changyi Yang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease
Ilenia Di Cola, Paola Cipriani, Piero Ruscitti
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 14, pp. 1577-1587
Closed Access | Times Cited: 5
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
Piero Ruscitti, Francesco Ursini, Yehuda Shoenfeld
Journal of Psychosomatic Research (2023) Vol. 169, pp. 111231-111231
Open Access | Times Cited: 2
Liver Involvement is Associated with Higher Risk of Rapidly Progressive Interstitial Lung Disease and Mortality in Anti-Melanoma Differentiation-Associated Gene 5 Antibody- Positive Dermatomyositis
Xin Yang, Xiaoguang Cui, Xiao Yang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3101-3113
Open Access
Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis
Sara Garcinuño, Antonio Lalueza, Francisco Javier Gil‐Etayo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Yuanyuan Niu, Suling Liu, Qian Qiu, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access
Adult-Onset Still’s Disease (AOSD)
María Kourilovitch, Claudio Galarza-Maldonado
(2024), pp. 31-36
Closed Access
Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis
Yan Wang, Hongxia Jia, Wei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Effect of High Serum Ferritin on Extent of Involvement of COVID-19 Associated Mucormycosis
Prahlada Nayaka Basavanthappa, C. Narayana Murthy, Sonam S. Nandyal, et al.
Indian Journal of Otolaryngology and Head & Neck Surgery (2023) Vol. 76, Iss. 2, pp. 1857-1861
Closed Access | Times Cited: 1
COVİD-19’LU YAŞLI HASTALARDA HİPERFERRİTİNEMİ HASTALIK ŞİDDETİ YÖNÜNDEN GÜVENİLİR MİDİR?
Muhammet Özbilen, Şeyda Tuba Savrun, Yeliz KAŞKO ARICI, et al.
Genel Tıp Dergisi (2023)
Open Access
Page 1

Scroll to top